International Stem Cell Corporation - podcast cover

International Stem Cell Corporation

-•internationalstemcell.podbean.com
Science & Medicine
is a biotechnology company developing therapeutic and research products through the use of human stem cells.
Last refreshed: ⓘ
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Follow on
Apple Podcasts
Spotify
RSS
YouTube
Overcast
Pocket Casts
Episodes.fm
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

The Ellis Martin Report: Interview with International Stem Cell Corporation's Founder/Co-Chairman

TEMR: Welcome to The Ellis Martin Report. I’m Bob Lange. We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO. International Stem Cell Corporation has been one of the most exciting companies trading in the biotech sector with respect to non-embryonic stem cell development. They have a proprietary process and commercial products that give them a tremendous edge in the marketplace. Ken welcome back to the show...

Oct 21, 2011•5 min

The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.

Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where I have the pleasure of interviewing Executive Chairman, Kenneth Aldrich. International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized ...

Aug 08, 2011•11 min

The Difference Between Adult Stem Cells and Embryonic Stem Cells

This is Ken Aldrich. I am Chairman of International Stem Cell Corporation and thought I’d talk for just a minute, or maybe a couple of minutes, about the different kinds of stem cells. People are always asking, “What’s the difference between an adult stem cell and an embryonic stem cell?” Let me try to make this as simple as possible. Adult stem cells are those that are derived from the human body any time after the first, probably, week or two of development of the fetus in the womb. So, cells ...

Apr 16, 2009•4 min

International Stem Cell Corporation Offers a Possible Alternative to Animal Corneal Testing

Please take a moment to listen to International Stem Cell Corporation Chairman, Ken Aldrich, as he discusses the benefits of using human corneas developed in Petri dishes as an alternative to testing on the eyes of innocent rabbits. This is Ken Aldrich and I am chairman of International Stem Cell Corporation and I am here to talk to you a little bit about rabbits. One of the things that most people don’t know is that cosmetic companies, drug companies and pesticide makers all have to test their ...

Apr 16, 2009•2 min

ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test

International Stem Cell Corporation (OTCBB:ISCO ( www.internationalstemcell.com ), the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO's parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems' know how in creating in vitro assay s...

Nov 25, 2008•4 min

International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co

International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network. “To work with a company such as Millipore that has sales of over $1.5 billion and is known throughout the world is a wonderful opportunity for ISCO. This partnership will lead to a significant expansion in ISCO’s revenue generation through the ma...

Sep 25, 2008•2 min

International Stem Cell Corporation Arranges $3 Million Equity Financing

OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO - News ) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, ...

Sep 13, 2008•2 min

Meet Ken Aldrich the co-founder of International Stem Cell Corporation

Welcome to this podcast. I am Ken Aldrich, Chairman and co-founder of International Stem Cell Corporation. International Stem Cell Corporation recently announced that our scientific team, led by our Chief Scientist, Dr. Elena Revazova, has created a new class of human stem cell lines that do not involve the use of fertilized eggs and may enable hundreds of millions of people of different sex, ages and racial groups to benefit from cell based therapy with cells that will not be rejected by the pa...

Dec 30, 2007•5 min
For the best experience, listen in Metacast app for iOS or Android